BGI
ASMB icon

B Group Inc’s Assembly Biosciences ASMB Stock Holding History

B Group Inc’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Hold
175,706
– – 2.27% 15
2026
Q1 		$4.88M Hold
175,706
– – 3.61% 12
2025
Q4 		$5.98M Hold
175,706
– – 4.41% 9
2025
Q3 		$4.5M Sell
175,706
-13,644
-7% -$299K 3.31% 8
2025
Q2 		$3.43M Sell
189,350
-10,650
-5% -$140K 2.64% 11
2025
Q1 		$1.91M Buy
200,000
+149,349
+295% +$1.95M 1.64% 9
2024
Q4 		$799K Buy
+50,651
New +$815K 0.49% 13

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

B Group Inc's ASMB Position: Q2 2026 in Review

B Group Inc held its Assembly Biosciences (ASMB) position steady in Q2 2026 at 175,706 shares worth $4.83M. The position accounts for 2.27% of the portfolio, ranked #15.

B Group Inc first reported a position in ASMB in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.98M in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • B Group Inc held 175,706 shares of Assembly Biosciences worth $4.83M as of Q2 2026.
  • B Group Inc left its Assembly Biosciences share count unchanged in Q2 2026.
  • Assembly Biosciences made up 2.27% of B Group Inc's portfolio in Q2 2026, its #15 holding.
  • B Group Inc first reported a position in Assembly Biosciences in Q4 2024 and has held it in 7 quarters since.
  • B Group Inc's Assembly Biosciences position peaked at $5.98M in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.